Fathom Pharma

Fathom Pharma Focuses on Developing New Therapies for Moderate to Severe Chronic Pain to Address Safety and Efficacy Gaps in Current Treatment Models. The Company's Lead Product, FP01, Was Initially Developed for Treating Chronic Pain in Patients with Terminal Illnesses.